These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11304841)

  • 1. Pulmonary preinvasive neoplasia.
    Kerr KM
    J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preneoplastic lesions of pulmonary carcinoma].
    Bubendorf L
    Pathologe; 2011 Nov; 32 Suppl 2():218-23. PubMed ID: 22033683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients.
    Smith AL; Hung J; Walker L; Rogers TE; Vuitch F; Lee E; Gazdar AF
    Br J Cancer; 1996 Jan; 73(2):203-9. PubMed ID: 8546907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer preneoplasia.
    Wistuba II; Gazdar AF
    Annu Rev Pathol; 2006; 1():331-48. PubMed ID: 18039118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
    Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
    Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
    PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preneoplastic lesions of the lung.
    Greenberg AK; Yee H; Rom WN
    Respir Res; 2002; 3(1):20. PubMed ID: 11980589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New WHO classification of lung adenocarcinoma and preneoplasia].
    Lantuejoul S; Rouquette I; Brambilla E; Travis WD
    Ann Pathol; 2016 Jan; 36(1):5-14. PubMed ID: 26791238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Herman JG
    Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.